Proove Biosciences Presents Successful Exhibit at American Pain Society’s 32nd Annual Meeting

IRVINE, Calif. - June 4, 2013 - PRLog -- Proove Biosciences, the leader in personalized pain medication innovation, is pleased to announce their exhibit at the American Pain Society’s 32nd Annual Scientific Meeting was well received, and one of the only organizations to demonstrate successful commercial application of genetic technology in pain management. Vice President of Research and Development, Dr. Ben Arthur, was present and exhibited Proove’s successes in identifying patients at risk for developing dependencies on narcotic drugs used in current pain treatments.

“We were very pleased with the interest and reception that our exhibit received at the APS’s Scientific Meeting.” Stated Dr. Arthur, adding that, “Our research efforts and proprietary laboratory testing have been able to provide a unique service to the healthcare industry; commercializing genetic technology in the treatment of pain is a new concept, and Proove Biosciences is leading the industry in translating this technology into personalizing pain management treatments.”

The APS’s 32nd Annual Scientific Meeting took place May 8th-11th, and addressed the latest science and most relevant topics facing pain practitioners. In attendance were industry leading pain physicians, scientists, and research organizations. Proove helps identify patients at risk for tolerance and misuse of medications, and has been creating efficiency within the healthcare system, while improving safety and decreasing risks associated with pain medicine therapies. Dr. Arthur is responsible for directing the Company’s R&D efforts and publication planning. His experience and background is in molecular genetics, neuroscience, applied Mathematics and informatics, technology entrepreneurship and business.

About Proove Biosciences
Proove Biosciences is the leader in Personalized Pain Medicine.  A research-driven company, Proove provides proof, such as genetic information, to improve the health of patients through proprietary laboratory testing services. Physicians order Proove testing to improve the selection, dosing, and evaluation of medications they prescribe and insurance companies reimburse for Proove testing to contain costs. From a simple cheek swab collected in the office, Proove Medical Laboratories performs proprietary genetic tests in its CLIA-certified laboratory to identify patients at risk for misuse of prescription pain medications and evaluate their metabolism of medications. Proove is based in Irvine, California and has an East Coast office in Howard County, Maryland. For more information, please visit www.proovebio.com or call toll free 855-PROOVE-BIO (855-776-6832).